# A systematic review and meta-analysis of the impact of relaxation techniques to reduce burden of disease in patients with psychotic disorders

**Authors:** Nina Schlößer, Christian Theisen, Eva Meisenzahl, Carolin Kieckhäfer

PMC · DOI: 10.1038/s41598-026-44310-0 · 2026-03-24

## TL;DR

This study reviews how relaxation techniques can help reduce symptoms in patients with psychotic disorders, finding moderate benefits especially in outpatient settings.

## Contribution

The study provides a meta-analysis showing that relaxation interventions can be beneficial as an add-on therapy for psychosis treatment.

## Key findings

- Relaxation interventions showed small to moderate effects on general, positive, and negative symptoms of psychosis.
- Patients in outpatient and rehabilitative settings benefited more from relaxation techniques than inpatient patients.
- No adverse effects of relaxation interventions were reported in the included studies.

## Abstract

The role of psychosocial stress as a factor in both the development of psychosis and the exacerbation of acute psychotic episodes is increasingly well understood. Various approaches to stress reduction have been shown to be helpful for psychosis patients, but they are rarely included in guidelines and treatment algorithms. In this systematic review and meta-analysis, we examined the effectiveness and potential adverse effects of interventions that specifically aim to reduce stress in psychosis patients. To do so, we systematically searched five databases (PubMed, Scopus, Web of Science, PsycINFO, Cochrane-Library) for studies on relaxation interventions in psychosis treatment. Of the identified studies, 24 (N = 1292 patients) were eligible for inclusion. We performed a systematic review and general meta-analysis and a subgroup analysis for patient setting (inpatient, outpatient, rehabilitative, or mixed). The general analysis showed small to moderate effects of the interventions on general, positive, and negative symptoms but not for the reduction of stress. In the subgroup analysis, psychosis patients in outpatient and rehabilitative settings benefitted more from the interventions than those in an inpatient setting. No adverse effects were reported. These results help to consider the integration of relaxation techniques for stress reduction as an add-on therapy in psychosis treatment.

The online version contains supplementary material available at 10.1038/s41598-026-44310-0.

## Linked entities

- **Diseases:** psychosis (MONDO:0005485)

## Full-text entities

- **Genes:** CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, SPINK5 (serine peptidase inhibitor Kazal type 5) [NCBI Gene 11005] {aka LEKTI, LETKI, NETS, NS, VAKTI}
- **Diseases:** cognitive impairment (MESH:D003072), psychiatric (MESH:D001523), obsessive-impulse disorder (MESH:D009771), organic psychoses (MESH:D000092124), psychosis (MESH:D011618), cardiovascular disease (MESH:D002318), chronic obstructive pulmonary disease (MESH:D029424), diabetes mellitus (MESH:D003920), neurological disease (MESH:D020271), pulmonary disease (MESH:D008171), schizophrenia (MESH:D012559), panic disorders (MESH:D016584), depression (MESH:D003866), type 2 diabetes (MESH:D003924), disease (MESH:D004194), HPA (MESH:D010661), anxiety (MESH:D001007), disorganized thinking and behavior (MESH:D012562), DSM (MESH:D001714), aggression (MESH:D010554), posttraumatic stress disorder (MESH:D013313)
- **Chemicals:** tai (-), dopamine (MESH:D004298)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** F23.X

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018224/full.md

---
Source: https://tomesphere.com/paper/PMC13018224